Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C, Genotype 1”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00377182
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 107
Large-scale testing (Phase 3)Ended earlyNCT02791256
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 23
Testing effectiveness (Phase 2)Study completedNCT02254707
What this trial is testing

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Post-approval studies (Phase 4)Study completedNCT00629967
What this trial is testing

Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

Who this might be right for
Chronic Hepatitis CGenotype
Kaohsiung Medical University Chung-Ho Memorial Hospital 200
Post-approval studies (Phase 4)WithdrawnNCT03143998
What this trial is testing

Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)WithdrawnNCT01579019
What this trial is testing

RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor Treatment

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT02105467
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 421
Not applicableStudy completedNCT00926016
What this trial is testing

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

Who this might be right for
Chronic Hepatitis C
Brooke Army Medical Center 23
Large-scale testing (Phase 3)Study completedNCT02032875
What this trial is testing

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 116
Testing effectiveness (Phase 2)Study completedNCT00148837
What this trial is testing

Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Who this might be right for
Hepatitis C, ChronicFibrosis
French National Agency for Research on AIDS and Viral Hepatitis 112
Large-scale testing (Phase 3)Study completedNCT03222583
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 546
Large-scale testing (Phase 3)Ended earlyNCT01718301
What this trial is testing

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin

Who this might be right for
Hepatitis CHIV InfectionsCOINFECTION
Anna Cruceta 108
Testing effectiveness (Phase 2)Study completedNCT01016912
What this trial is testing

Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients

Who this might be right for
Hepatitis C Infection
Bristol-Myers Squibb 51
Large-scale testing (Phase 3)Study completedNCT01358864
What this trial is testing

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 678
Very early researchEnded earlyNCT00882193
What this trial is testing

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Who this might be right for
Chronic Hepatitis CGenotype 1Relapse
University of Nebraska 2
Post-approval studies (Phase 4)Ended earlyNCT00977054
What this trial is testing

Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load

Who this might be right for
Hepatitis C
National Taiwan University Hospital 59
Large-scale testing (Phase 3)Study completedNCT03069365
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 101
Post-approval studies (Phase 4)UnknownNCT00127777
What this trial is testing

Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA)

Who this might be right for
Hepatitis C, Chronic
University Hospital, Saarland 700
Post-approval studies (Phase 4)Study completedNCT00351403
What this trial is testing

Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
FGK Clinical Research GmbH 390
Testing effectiveness (Phase 2)Study completedNCT01445795
What this trial is testing

Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Virus, Treatment-naïve Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 50
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation